Details for New Drug Application (NDA): 021383
✉ Email this page to a colleague
NDA 021383 describes CITANEST FORTE DENTAL, which is a drug marketed by Dentsply Pharm and is included in one NDA. Additional details are available on the CITANEST FORTE DENTAL profile page.
The generic ingredient in CITANEST FORTE DENTAL is epinephrine bitartrate; prilocaine hydrochloride. There are twenty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the epinephrine bitartrate; prilocaine hydrochloride profile page.
The generic ingredient in CITANEST FORTE DENTAL is epinephrine bitartrate; prilocaine hydrochloride. There are twenty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the epinephrine bitartrate; prilocaine hydrochloride profile page.
Summary for 021383
| Tradename: | CITANEST FORTE DENTAL |
| Applicant: | Dentsply Pharm |
| Ingredient: | epinephrine bitartrate; prilocaine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.005MG/ML;4% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | Yes | ||||
Complete Access Available with Subscription
